| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |